These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 4325153)

  • 21. [Mechanism of action and effectiveness of intravenous administration of tubazid, streptomycin and PAS in the therapy of pulmonary tuberculosis].
    Pilipchuk NS; Ivaniuota OM; Kovalenko NN
    Probl Tuberk; 1970; 48(1):26-30. PubMed ID: 5425441
    [No Abstract]   [Full Text] [Related]  

  • 22. [The hemogram and ESR in pulmonary tuberculosis during intravenous administration of the primary antitubercular drugs].
    Koviazina AI; Utkin VV
    Probl Tuberk; 1971; 49(2):48-51. PubMed ID: 5561919
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effectiveness of intermittent chemotherapy in the combined treatment of patients with recently diagnosed destructive tuberculosis of the lungs].
    Osiĭnskiĭ IIu; Berezovskiĭ BA
    Probl Tuberk; 1989; (5):56-9. PubMed ID: 2748559
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparison of combination therapy of Capreomycin, ethionamide and cycloserin with that of kanamycin, ethionamide and cycloserin for the retreatment of pulmonary tuberculosis].
    Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
    Saishin Igaku; 1970 Jul; 25(7):1546-55. PubMed ID: 5451178
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ambulatory and hospitalintermittent intravenous chemotherapy of pulmonary tuberculosis in a rural district].
    Ursov IG; Volokitin FN; Kononenko VG
    Sov Med; 1979 Apr; (4):108-10. PubMed ID: 375418
    [No Abstract]   [Full Text] [Related]  

  • 26. [Certain aspects of new combinations of drugs for the treatment of drug-resistant tuberculosis].
    Jancík E; Novák M; Jancíková M; Tousek J; Krátký J; Feitová S; Zelenka M
    Bull Int Union Tuberc; 1968 Dec; 41():188-91. PubMed ID: 5710247
    [No Abstract]   [Full Text] [Related]  

  • 27. [The function of the cardiovascular system in patients with pulmonary tuberculosis treated by intravenous administration of streptomycin, tubazid and PAS].
    Golanov VS
    Vrach Delo; 1969 Jun; 6():62-6. PubMed ID: 5821665
    [No Abstract]   [Full Text] [Related]  

  • 28. [Kanamycin and florimycin in the clinical course of pulmonary tuberculosis].
    Bialik IB
    Antibiotiki; 1971 Feb; 16(2):184-8. PubMed ID: 4326728
    [No Abstract]   [Full Text] [Related]  

  • 29. [New combinations of drugs for the treatment of drug-resistant tuberculosis].
    Schmelev NA
    Bull Int Union Tuberc; 1968 Dec; 41():192-3. PubMed ID: 5710248
    [No Abstract]   [Full Text] [Related]  

  • 30. RECENT ADVANCES IN TREATMENT OF ORGAN TUBERCULOSIS.
    PFUETZE KH; PYLE MM
    JAMA; 1964 Mar; 187():805-10. PubMed ID: 14094316
    [No Abstract]   [Full Text] [Related]  

  • 31. [Urgent problems of antibacterial treatment of pulmonary tuberculosis].
    Pilipchuk NS
    Vrach Delo; 1981 Jan; (1):47-9. PubMed ID: 7010782
    [No Abstract]   [Full Text] [Related]  

  • 32. Intermittent chemotherapy or improvement of initial treatment in tuberculosis.
    Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1971 Jul; 18(1):1-6. PubMed ID: 4949334
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
    Fegiz G
    Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
    [No Abstract]   [Full Text] [Related]  

  • 34. General considerations in intermittent drug therapy of pulmonary tuberculosis.
    Fox W
    Postgrad Med J; 1971 Nov; 47(553):729-36. PubMed ID: 4110537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duration of application and change of a regimen with secondary drugs.
    Oka S; Takase Y; Kato S
    Sci Rep Res Inst Tohoku Univ Med; 1968 Oct; 15(1):46-9. PubMed ID: 4308926
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical experience in the single administration of daily doses of chemical preparations].
    Pozdniakova EI; Matiashvili NA
    Probl Tuberk; 1970; 48(4):89-90. PubMed ID: 5471139
    [No Abstract]   [Full Text] [Related]  

  • 37. [Four drug combination including Ethambutol and early switching to entirely new regimen in initial treatment of pulmonary tuberculosis].
    Kekkaku; 1970 Jul; 45(7):219-26. PubMed ID: 5449509
    [No Abstract]   [Full Text] [Related]  

  • 38. The syndrome of open cavity healing.
    Zierski M
    Scand J Respir Dis Suppl; 1968; 65():151-6. PubMed ID: 4978459
    [No Abstract]   [Full Text] [Related]  

  • 39. [Healing of destructive pulmonary tuberculosis depending on bacteriostatic effect of various methods of treatment].
    Sokolova GB; Galenko NN; Kanevskaia SS
    Probl Tuberk; 1978 Nov; (11):30-5. PubMed ID: 103090
    [No Abstract]   [Full Text] [Related]  

  • 40. Two-phase chemotherapy of pulmonary tuberculosis.
    Bhatia JL; Thind GS
    J Indian Med Assoc; 1969 Nov; 53(9):443-9. PubMed ID: 4189572
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.